Skip to main content
Clinical Trials/NCT00637299
NCT00637299
Completed
Early Phase 1

Osteopathic Treatment May Improve Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease

Fondazione Salvatore Maugeri1 site in 1 country20 target enrollmentJanuary 2008

Overview

Phase
Early Phase 1
Intervention
Not specified
Conditions
Chronic Obstructive Pulmonary Disease
Sponsor
Fondazione Salvatore Maugeri
Enrollment
20
Locations
1
Primary Endpoint
Walking Ability
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

The purpose of this trial is to verify if an osteopathic treatment added to usual pulmonary rehabilitation trial is able to improve the walking ability of COPD patients and if there is any influence on lung functionality.

Detailed Description

The investigators decided to perform an osteopathic manipulative treatment (OMT) in a population of COPD patients. OMT was defined as the therapeutic application of manually guided forces by an osteopathic practitioner to improve physiologic function and/or support homeostasis that has been altered by somatic dysfunction. Concerning the respiratory system, osteopathy considers a model that describes the interdependent functions among five body components as follows: 1: the inherent motility of the brain and spinal cord; 2: fluctuation of the cerebrospinal fluid; 3: mobility of the intracranial and intraspinal membranes; 4: articular mobility of the cranial bones; 5: the involuntary mobility of the sacrum between the ilia. This model is the so called primary respiratory mechanism.

Registry
clinicaltrials.gov
Start Date
January 2008
End Date
November 2008
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ercole Zanotti

MD

Fondazione Salvatore Maugeri

Eligibility Criteria

Inclusion Criteria

  • patients affected by COPD

Exclusion Criteria

  • other diseases other than COPD

Outcomes

Primary Outcomes

Walking Ability

Time Frame: 4 weeks

6 minutes walking test (6MWT)

Secondary Outcomes

  • Lung Function Test(4 weeks)

Study Sites (1)

Loading locations...

Similar Trials